Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat with Fludarabine and Cytarabine in Pediatric AML/MDS
NCT02676323Phase 1Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of panobinostat in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), sponsored by St. Jude Children's Research Hospital. Started May 2016; status: terminated.
02
Drugs
panobinostat
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02676323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676323.